GDF15 and posterior cortical atrophy: Biomarkers that individually showed a statistically significant difference in serum levels between AG and low risk PCa patients included GDF-15 (p<0.01), %fPSA (p<0.05, lower in AG), and Fuc-PSA, PSA, and phi (all at p<0.0001).